drugset / Trial / NCT07345845

MR and Inflammation After Preeclampsia

NCT07345845

Phase 0 Active not recruiting 40 enrolled Anna Stanhewicz, PhD
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this investigation is to examine the role of inappropriate mineralocorticoid receptor activation in endothelial dysfunction and vascular inflammation in otherwise healthy women with a history of preeclampsia. The main questions it aims to answer are: 1. Does overactivation of the mineralocorticoid receptor contribute to reduced endothelial function in women who had preeclampsia? 2. To what extent does the mineralocorticoid receptor mediated exaggerated production of inflammatory cytokines in immune cells from women who had preeclampsia? Participants will visit the research laboratory for 2 experimental visits: * Visit 1: Skin blood flow will be measured using a minimally invasive technique (intradermal microdialysis for the local delivery of pharmaceutical agents) to examine blood vessels in a nickel-sized area of the skin. * Visit 2: Endothelial cells will be collected from an antecubital vein.

Timeline

Start
2025-12-17
Primary completion
2028-02-01
Completion
2029-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Eplerenone Unknown Other

Indications